Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹349Cr
Rev Gr TTM
Revenue Growth TTM
30.76%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

AARTISURF
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 4.3 | -6.0 | -5.2 | 3.9 | 0.5 | -3.6 | 4.8 | 17.3 | 27.4 | 50.5 | 18.8 | 27.6 |
| 144 | 134 | 128 | 122 | 144 | 134 | 147 | 154 | 182 | 204 | 170 | 195 |
Operating Profit Operating ProfitCr |
| 8.8 | 10.0 | 11.3 | 12.1 | 9.0 | 6.7 | 2.5 | 5.5 | 9.8 | 5.4 | 5.2 | 6.1 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Depreciation DepreciationCr | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 6 | 8 | 9 | 9 | 7 | 3 | 3 | 1 | 13 | 4 | 2 | 5 |
| 1 | 2 | 4 | 2 | 2 | 1 | 1 | 0 | 3 | 1 | 1 | 1 |
|
Growth YoY PAT Growth YoY% | 97.9 | 41.5 | 1,381.3 | 67.8 | -0.8 | -57.7 | -61.8 | -88.0 | 109.0 | 32.4 | -13.8 | 357.5 |
| 3.0 | 3.5 | 3.3 | 4.8 | 2.9 | 1.6 | 1.2 | 0.5 | 4.8 | 1.4 | 0.9 | 1.8 |
| 6.2 | 6.6 | 6.0 | 8.4 | 5.8 | 2.6 | 2.1 | 0.9 | 11.5 | 3.5 | 1.8 | 4.3 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 42.9 | 23.6 | 4.5 | -1.9 | 11.7 | 22.1 |
| 302 | 420 | 543 | 554 | 528 | 617 | 752 |
Operating Profit Operating ProfitCr |
| 7.2 | 9.8 | 5.6 | 7.9 | 10.5 | 6.4 | 6.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 8 | 1 |
Interest Expense Interest ExpenseCr | 10 | 10 | 11 | 15 | 14 | 12 | 13 |
Depreciation DepreciationCr | 11 | 12 | 12 | 15 | 16 | 17 | 18 |
| 3 | 23 | 9 | 18 | 32 | 21 | 25 |
| 1 | 1 | 4 | 5 | 11 | 6 | 7 |
|
| | 937.1 | -74.6 | 131.2 | 67.9 | -31.8 | 22.9 |
| 0.6 | 4.6 | 0.9 | 2.1 | 3.6 | 2.2 | 2.2 |
| 2.8 | 28.1 | 7.1 | 16.6 | 26.6 | 17.2 | 21.1 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| 103 | 125 | 128 | 160 | 210 | 224 | 228 |
Current Liabilities Current LiabilitiesCr | 95 | 164 | 149 | 142 | 129 | 186 | 184 |
Non Current Liabilities Non Current LiabilitiesCr | 56 | 89 | 117 | 94 | 75 | 58 | 69 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 94 | 175 | 175 | 182 | 200 | 252 | 250 |
Non Current Assets Non Current AssetsCr | 168 | 211 | 227 | 221 | 223 | 225 | 240 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 18 | 36 | 23 | 25 | 52 | 11 |
Investing Cash Flow Investing Cash FlowCr | -2 | -60 | -23 | -11 | -16 | -16 |
Financing Cash Flow Financing Cash FlowCr | -16 | 32 | -6 | -8 | -37 | 0 |
|
Free Cash Flow Free Cash FlowCr | -7 | -25 | 1 | 14 | 36 | -9 |
| 868.2 | 164.1 | 424.4 | 193.0 | 243.6 | 76.6 |
CFO To EBITDA CFO To EBITDA% | 76.8 | 78.0 | 72.5 | 51.4 | 83.6 | 26.6 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 707 | 570 | 360 | 468 | 339 |
Price To Earnings Price To Earnings | 0.0 | 32.7 | 103.7 | 28.3 | 22.0 | 23.3 |
Price To Sales Price To Sales | 0.0 | 1.5 | 1.0 | 0.6 | 0.8 | 0.5 |
Price To Book Price To Book | 0.0 | 5.3 | 4.2 | 2.1 | 2.1 | 1.5 |
| 4.6 | 18.7 | 22.7 | 10.5 | 9.0 | 10.7 |
Profitability Ratios Profitability Ratios |
| 24.1 | 24.6 | 20.9 | 21.1 | 24.3 | 18.9 |
| 7.2 | 9.8 | 5.6 | 7.9 | 10.5 | 6.4 |
| 0.6 | 4.6 | 0.9 | 2.1 | 3.6 | 2.2 |
| 6.0 | 11.7 | 6.7 | 10.3 | 14.6 | 9.4 |
| 1.9 | 16.3 | 4.0 | 7.6 | 9.8 | 6.3 |
| 0.8 | 5.6 | 1.4 | 3.1 | 5.0 | 3.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Aarti Surfactants Limited (ASL) is a leading Indian manufacturer of specialty surfactants, serving both domestic and international markets across over 30 countries. The company was incorporated on **June 18, 2018**, and began independent operations on **July 8, 2019**, following the demerger of the Home and Personal Care (HPC) division from Aarti Industries Limited. Its shares are listed on the **BSE and NSE** since July 14, 2020. The company is promoted by **Shri Parimal Hasmukhlal Desai** and **Shri Chandrakant Vallabhaji Gogri**.
ASL specializes in **customized, sustainable surfactant solutions** for the **Home Care, Personal Care, Agrochemicals, Oilfield, and Industrial sectors**, with a strong focus on **ionic and non-ionic surfactants**.
---
### **Operations & Manufacturing**
ASL operates **two advanced manufacturing units**:
- **Pithampur, Madhya Pradesh**: Houses a **sulfonation unit** for producing Sulfonated Compounds on an active basis.
- **Silvassa, Dadra and Nagar Haveli**: Offers strategic **logistical advantages** due to proximity to major Indian ports and FMCG clusters, enabling faster delivery and cost efficiency.
Both facilities are equipped with **cutting-edge technology, in-house R&D teams, and quality certifications**, ensuring high-performance, consistent products. The company ensures **timely delivery** through an extensive and agile domestic and international distribution network.
---
### **Research & Development**
ASL has strengthened its innovation capabilities with the commissioning of a **dedicated R&D Centre in Navi Mumbai (Aug 2025)**. Key features include:
- Advanced analytical tools and formulation laboratories
- Pilot-scale equipment and digital monitoring systems
- Focus on **product development, process optimization, and sustainability**
The R&D team (over 11 qualified professionals) drives end-to-end innovation—from market insight to commercialization—particularly in **eco-friendly, biodegradable, and bio-based surfactants**. The center supports co-development with **FMCG partners, academic institutions, and global innovators**.
---
### **Product Portfolio & Applications**
ASL offers over **50+ products**, including:
- Primary surfactants (anionic, cationic, non-ionic)
- Mild surfactants for sensitive skin
- Pearlizing agents, preservatives, UV filters, conditioning agents
- Customized blends for formulations
**Key Applications**:
- Shampoos, body washes, soaps, hand wash
- Dishwashing liquids, detergents, surface cleaners
- Lotions, sunscreens, moisturizers
- Agrochemical formulations, oilfield applications, industrial cleaners
The company emphasizes **clean-label, ethically sourced, and sustainable ingredients** to meet evolving consumer and regulatory demands.
---
### **Market Position & Clients**
ASL is one of India’s largest manufacturers of specialty surfactants and a **preferred supplier to global FMCG giants**, including:
- **Hindustan Unilever**
- **Procter & Gamble**
- **Dabur**
- **Patanjali**
**Customer Concentration**: Top 3 clients accounted for **~68% of FY24 sales**, though entrenched relationships and high supplier qualification barriers provide stability.
ASL exports **~28% of its output** to key markets: USA, Europe, UAE, Saudi Arabia, Russia, Australia, and Southeast Asia. It positions itself as a **strategic supplier** through innovation, reliability, and responsive service.
---
### **Competitive Landscape**
ASL operates in a **highly competitive environment**, facing competition from:
- **Global players**: BASF, Croda, Clariant, Solvay, Evonik, Stepan, Dow
- **Domestic players**: Galaxy Surfactants (largest pure-play competitor)
Competitive advantages:
- **Robust R&D** and customization capability
- **Operational agility** and backward integration
- Strong **supplier and customer relationships**
- Strategic **geographic positioning** and cost-competitive manufacturing
However, ASL faces **pricing pressure, raw material volatility, and customer concentration risk**.
---
### **Strategic Initiatives & Growth Roadmap**
1. **Global Expansion**:
- Establish **application development centers, regional warehouses, and sales offices** in high-growth geographies: **Asia-Pacific, Middle East, and Africa**.
- Strengthen ties with **multinational FMCG clients** through technical collaborations and localized support.
2. **M&A and Collaborations**:
- Pursue **mergers, acquisitions, and joint ventures** to acquire niche technologies.
- Target **international firms restructuring under margin pressure** for eco-friendly chemistries.
3. **Product & Technology Development**:
- Expand into **high-margin, premium surfactants** (e.g., mild, multifunctional, bio-based).
- Develop formulations using **renewable raw materials**, aligned with **global sustainability standards**.
4. **Sustainability & ESG Focus**:
- Integrate **water recycling, energy efficiency**, and **renewable energy** into manufacturing.
- Offer **end-to-end formulation support** with rapid sampling to reduce customer time-to-market.
5. **Logistics & Supply Chain Resilience**:
- Mitigate global disruptions (e.g., port congestion, Suez diversions, tariffs) through:
- Diversified sourcing
- Logistics optimization
- Flexible operations
---
### **Challenges**
- **Raw material price volatility** due to geopolitical factors and U.S. reciprocal tariffs
- **Elevated freight and shipping costs**
- **Intense competition** leading to margin pressure
- **Dependence on key customers** and global macroeconomic conditions
---